Skip to Content
Uncategorized

Stem Cells Help Night-Blind, Bald, Heartbroken Mice

Three dramatic results from tests of stem cell therapies could one day be repeated in humans.

Nature News reports today on three different studies that successfully used stem cell therapies to sprout new hair on bald mice, restore some vision to night-blind mice, and improve the heart function of mice with a cardiac injury. All three methods could eventually be adapted for use in humans.

Robert Lanza, Chief Scientific Officer at Advanced Cell Technologies, a regenerative medicine biotechnology company, told Nature:

“By the time we grow old, doctors are going to look back and say, ‘Can you believe people used to go bald, go blind or even have their leg cut off from vascular disease?’ —then [they] will treat the problem with an injection of [stem] cells.”

In January Lanza’s company reported that embryonic stem cells could be safely injected into the eyes of human patients suffering deteriorating vision, although the efficacy of the treatment is unknown.

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

ChatGPT is going to change education, not destroy it

The narrative around cheating students doesn’t tell the whole story. Meet the teachers who think generative AI could actually make learning better.

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.